Skip to main content

What Makes CBD Hemp Oil Effective For Anxiety?

If you yourself don’t deal with anxiety, odds are someone you know suffers from a condition that’s rooted in this natural, fear-based response. Nearly 20 percent of U.S adults are affected by anxiety and anxiety-based disorders.

It’s not difficult to see why so many people are affected by feelings of apprehension, nervousness, or panic on a regular basis; modern life can be fast and hectic and that can trigger base responses that make us feel as though we might be in danger. These feelings can be normal and natural for a healthy brain. Sometimes, however, they come about frequently or severely, and can indicate that something is very wrong.

Sometimes anxiety disorders aren’t always manifested as panic attacks or hypersensitive responses, which can be the case with disorders like PTSD or social anxiety disorder; obsessive-compulsive disorders are also characterized as anxiety disorders. In these conditions, repetitive behaviors, hypervigilance, and ritualistic actions are more common symptoms.

No matter how symptoms present themselves, anxiety disorders can prevent people from living normal, productive lives and can lead to other unhealthy issues, including social isolation, depression, insomnia, and a range of other difficulties. This is why it’s important to find reliable treatments.

Apart from resources like counseling, cognitive behavioral therapies, and healthy coping techniques, there is a range of different medications that are used to target parts of the brain where anxiety responses originate. Many of these medications are meant to alter the release and reception of certain chemicals that affect mood and cognitive behavior, including feelings of anxiety and apprehension, such as serotonin.

Other treatments are focused on neurogenesis, also known as the creation of new neurons, in the hippocampus. The hippocampus portion of the brain is significant in treating anxiety as it plays an important role in memory formation and cognition. Patients with untreated depression and anxiety often have a smaller hippocampus compared to those who are undergoing or have undergone successful treatments.

When asking does CBD hemp oil help with anxiety, the answer may lie with these mechanisms. Some studies have shown that cannabidiol can have a similar effect to medications that affect serotonin reuptake in the brain, specifically SSRIs like Prozac and Zoloft. Some animal-based research and now a limited number of human-based studies show that CBD can produce an anti-anxiety effect that’s comparable with these antidepressant-based therapies, which are also used to control anxiety responses. Anxiety caused by traumatic memories, such as in cases of PTSD, may be helped by CBD’s effect on neurogenesis in the hippocampus.

If you’re considering using CBD hemp oil for anxiety, you’ll want to speak with your doctor first. Making any abrupt changes to medication or therapy programs for issues with anxiety, depression, and other psychiatric difficulties can have serious and dangerous consequences. If you and your doctor determine that CBD will be an effective and safe option for your needs, their guidance can make all the difference in getting positive and manageable results.

Original Article Source: https://blog.puredosage.com/cbd-hemp-oil/effective-for-anxiety

Comments

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...